1Y Close · As of Aug 26, 2026
InBody operates in the Medical, Precision & Optical sector.
Legal name: InBody Co., Ltd.
In fiscal year 2025, InBody (041830) reported revenue of 233.9 billion KRW, up 14.4% from 204.5 billion KRW a year earlier.
Operating profit was 36.8 billion KRW and net income was 30.0 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 812.9 billion KRW, with a P/B of 2.54.
These figures can be verified in the DART filing (receipt no. 20260318001304).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 233.9B | 36.8B | 30.0B |
| 2024 | 204.5B | 36.7B | 32.7B |
| 2023 | 170.4B | 38.3B | 36.6B |
Recent Filings
Treasury Stock Disposal Result
Semi-Annual Report (2026.06)
Large Shareholding Report (Simplified)
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 6 disposal(s).
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Treasury Stock Disposal Result |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-12 | Large Shareholding Report (Simplified) |
| 2026-08-06 | Consolidated Operating (Preliminary) Earnings (Fair Disclosure) |
| 2026-08-06 | Material Event Report (Treasury Disposal Decision) |